GLP1R and Anorexia: However, when coadministered with GLP-140, GIP-085 was able to reduce kaolin consumption driven by GLP-1R activation and it also significantly attenuated GLP-140–induced anorexia at 72 hours, resulting in a 7- ± 6-g significant attenuation of GLP-140–induced body weight loss.